Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

Gene Therapy

Volumn 4, Issue 2, 1997, Pages 82-92

  Mucke S ^a   Polack, A ^b   Pawlita, M ^c   Zehnpferunig, D ^b   Massoudi, N ^a   Bohlen, H ^a   Doerfler, W ^a   Bornkamm, G ^b   Diehl, V ^a   Wolf, J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Inst Clin Molecularbiology and T   (Germany)

^c Res Programm Applied Tumor Virology   (Germany)

Author keywords

Cytokine gene transfection; EBV latent origin of replication; Episomally replicating plasmids; Malignant lymphoma

Indexed keywords

BETA GALACTOSIDASE; CANCER VACCINE; CHLORAMPHENICOL ACETYLTRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BURKITT LYMPHOMA; CANCER IMMUNIZATION; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; NONHODGKIN LYMPHOMA; PLASMID; PRIORITY JOURNAL;

FELIS CATUS; HUMAN HERPESVIRUS 4; MUS MUSCULUS;

EID: 8044248412     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300363     Document Type: Article

References (46)

1. Watanabe Y et al. Exogenous expression of mouse interferorvγ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity. Proc Natl Acad Sci USA 1989; 86: 9456-9640.
2. Gansbacher B et al. Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 1990, 172. 1217-1224.
3. Fearon ER et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990; 60: 397-403.
4. Miller AR, McBride WH, Hunt K, Economou JS. Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1994; 1: 436-450.
5. Hock H et al. Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy. Nat Immunol 1994; 13: 85-92.
6. Fujiwaia T, Grimm EA, Roth JA Gene therapeutics and gene therapy for cancer. Curr Opin Oncol 1994, 6: 96-105.
7. Campbell MJ et al. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 1990; 145: 1029-1036.
8. Bernstein M, Starnes CO, Levy R. Specific enhancement of the therapeutic effect of anti-idiotypic antibodies on a murine B cell lymphoma by IL-2. J Immunol 1988; 140: 2839-2843.
9. Tao MH, Levy R. Idiotype/granulocyte - macrophage colony-stimulating factor fusion protein as a vaccine for B-cell Iymphoma. Nature 1993; 362: 755-758.
10. Helsop HE. Cytokine gene transfer in the therapy of malignancy Baillière's Clin Hematol 1994; 7: 135-151.
11. Banerjee S, Livanos E, Vos JMH. Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus. Nat Med 1995; 12: 1303-1308.
12. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1982; 1: 327-341.
13. Wolf J, Pawlita M, Bullerdiek J, zur Hausen H. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus immortalized lymphoblastoid cells despite deregulated c-myc gene expression. Cancer Res 1990; 50: 3095-3100.
14. Culver KW, Ram Z, Wallbridge S. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
15. Cardoso JE, Branchereau S, Jeyaraj PR. In situ retrovirus-mediated gene transfer into dog liver. Hum Gene Ther 1993; 4: 411-118.
16. Li Q, Kay MA, Finegold M. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403-409.
17. Russell SW, Miller AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S-phase. Proc Natl Acad Sci USA 1994; 91: 8915-8919.
18. Fink FJ, Sternberg LR, Weber PC. In vivo expression of β-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther 1992; 3: 11-19.
19. Moss B, Flexner C. Vaccinia virus expression vectors. Annu Rev Immunol 1987; 5: 305-324.
20. Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455-460.
21. Anderson WF. Human gene therapy. Science 1992; 256: 808-813.
22. Yang R, Nunes FA, Berencsi K. Cellular immunity to vital antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
23. Dubensky TW, Campbell BA, Villareal LP. Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci USA 1984; 81: 7529-7533.
24. Wolff JA, Malone R, Williams P. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
25. Feigner PL, Ringold GM. Cationic liposome-mediated transfection. Nature 1989; 337: 387-388.
26. Perales JC, Ferkol T, Beegen H. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci USA 1994; 91: 4084-4090.
27. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263: 14621-14624.
28. Middleton T, Sugden B. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1 J Virol 1994; 68: 4067-4071.
29. Rittner K, Sloppier H, Pawlita M, Sczakiel G. Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression. Meth Mol Cell Biol 1991; 2: 176-181.
30. Oehm A et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992; 267: 10709-10715.
31. Kischkel FC et al Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14: 5579-5588.
32. Diehl V, Henle G, Henle W, Kohn G. Demonstration of a Herpes group virus (EBV) in cultures of peripheral leucocytes from patients with infectious mononucleosis. J Virol 1968; 2: 366-371.
33. Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 1992; 3: 297-307.
34. Jones JF et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. New: Engl J Med 1988; 318: 733-738.
35. Wolf H, Haus M, Wilmes E. Persistence of Epstein-Barr virus in the parotid gland. J Virol 1984; 51: 795-801.
36. Greenspan JS et al. Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, and AIDS-associated lesion. New Engl J Med 1985; 313: 1564-1569.
37. Lee ES et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. New Engl J Med 1995; 332: 19-25.
38. Polack A, Eick D, Koch E, Bornkamm GW. Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells. EMBO J 1987; 6: 2959-2964.
39. Polack A, Feederle R, Klobeck G, Hörtnagel K. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J 1993; 12: 3913-3920.
40. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989.
41. Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 1986; 5: 2529-2537.
42. Wang AM et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985; 228: 149-153.
43. Wong GG et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810-815.
44. Menezes J, Leibold G, Klein G, Clements G. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid cell line (BJA-B) from an exceptional, EBV-genome negative African Burkitt's lymphoma. Biomedicine 1975; 22: 276-284.
45. Potter H, Weir L, Leder P. Enhancer-dependent expression of human k immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 1984; 81: 7161-7165.
46. Feinberg A, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1994; 137: 266-270.